Buch, Englisch, 343 Seiten, Format (B × H): 173 mm x 246 mm, Gewicht: 787 g
Buch, Englisch, 343 Seiten, Format (B × H): 173 mm x 246 mm, Gewicht: 787 g
Reihe: Progress in Inflammation Research
ISBN: 978-3-7643-6595-0
Verlag: Springer
This book gives a comprehensive overview of disease-modifying antirheumatic drugs (DMARDs). The introductory general chapters deal with the chemistry of DMARDs, their use in therapy, pharmacoeconomics, and a survey of opinion leaders in the field; the following specific chapters characterize each agent with regard to mechanism of action, therapy, pharmacology, efficacy, toxicity, and monitoring. For each agent some background is given, recent developments and influence of the treatment on patients` quality of life and long-term outcomes are presented.
Zielgruppe
Research
Autoren/Hrsg.
Fachgebiete
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Pharmakologie, Toxikologie
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Rheumatologie, Muskelerkrankungen
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Infektionskrankheiten
Weitere Infos & Material
Medicinal chemistry of the disease modifying anti-rheumatic drugs.- Targeting DMARD therapy.- Pharmacoeconomic properties of disease-modifying antirheumatic drugs.- Future molecular targets.- Hydroxychloroquine.- Sulfasalazine.- Parenteral gold.- Azathioprine.- Methotrexate.- Leflunomide.- Cyclosporin.- Tetracyclines.- Systemic glucocorticoids in rheumatoid arthritis.- TNF-? inhibitors.- Anakinra in rheumatoid arthritis.- Combination therapy.- Hematopoietic stem cell transplantation for the treatment of severe autoimmune diseases.
